MA
Mayne Pharma Group Limited
MAYNF · OTC
$2.15 -6.52% (-$0.15)
1M -6.52%
Market Cap $262.6M
P/E Ratio 10.74x
Div. Yield -
ROE 6.27%
Bulios Fair Price
$1.9
11.6% downside
Trenutna cena
$2.15
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MAYNF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
89 /100
Cheap P/E 10.74x
P/FCF 20.75x
EV/EBITDA 7.61x
Growth
78 /100
Growing Rev. growth 27.79%
Book val. growth 14.94%
EPS growth N/A
Profitability
37 /100
Moderate Gross margin 50.10%
FCF margin 3.30%
Net margin 6.38%
Quality
18 /100
Poor ROIC 4.33%
Asset turnover 0.42x
ROE 6.27%
Debt
74 /100
Low Debt/Equity 0.11x
Net debt/EBITDA -1.33x
Current ratio 1.31x
Stability
39 /100
Moderate Beta 1.00x
Profitable years 1
Rev. volatility 64.86%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MAYNF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Aaron Gray
Employees
450
Headquarters
Salisbury South
Prihajajoči dogodki
24 FEB.
Earnings
Upcoming earnings report